Brazil Approves First Generic Semaglutide Pen
Listen to the story
Anvisa, Brazil's national health regulator, has approved the country's first generic version of a semaglutide weight-loss pen.
Semaglutide is a drug that has become very popular around the world for treating obesity and, in some cases, diabetes.
Until now, semaglutide injection pens sold in Brazil were only made by the original manufacturer. This kept prices high for many patients.
With Anvisa's approval, a generic version can now be sold. A generic medicine contains the same active drug as the original, but it is usually cheaper.
This approval could make weight-loss treatment more affordable for many Brazilians who cannot pay the current high prices.
Anvisa checks that generic medicines are safe and work in the same way as the original product before allowing them to be sold.
The agency has confirmed that this new pen meets its safety standards.
Health experts say that lower prices could lead to wider access to obesity treatment in Brazil.
Semaglutide pens are usually given through a small injection under the skin, often once a week.
The approval marks an important step in Brazil's growing market for weight-loss medicines.
More generic versions from other companies may follow in the coming months, as demand for these drugs continues to rise.
Vocabulary10 words
- Anvisa
- Brazil's agency that checks medicines and food
- generic
- a cheaper copy of a well-known medicine
- semaglutide
- a drug used to help with weight loss
- original manufacturer
- the company that first made the medicine
- active drug
- the main substance that makes a medicine work
- safety standards
- the rules that show a product is not dangerous
- obesity
- having too much extra body weight
- diabetes
- a health problem with blood sugar
- approval
- official permission to sell or use something
- injection
- putting medicine into the body with a small needle
Quiz
Answer key
1. The first generic semaglutide pen in Brazil 2. It is usually cheaper than the original 3. As an injection under the skin
Fill-in-the-blank listening
Play the audio again and fill in the missing words as you listen.
Anvisa, Brazil's national health _____, has approved the country's first generic version of a semaglutide weight-loss pen.
Semaglutide is a drug that has become very _____ around the world for treating obesity.
Until now, semaglutide pens sold in Brazil were only made by the original _____.
A generic medicine contains the same active drug as the original, but it is usually _____.
This approval could make weight-loss treatment more _____ for many Brazilians.
Anvisa checks that generic medicines are _____ and work like the original before allowing sales.
The agency has confirmed that this new pen meets its safety _____.
Lower prices could lead to wider _____ to obesity treatment in Brazil.
Semaglutide pens are usually given through a small _____ under the skin.
More generic versions from other companies may follow as _____ for these drugs continues to rise.
Discussion questions
- Do you think cheaper weight-loss medicines will help more people in your country?
- Why do you think original medicines are often more expensive than generic ones?
- Should governments help control the price of important medicines like this?
- What are some possible risks of more people using weight-loss drugs?